Shares of PB Fintech, parent entity of ref=”dofollow” data-ga-onclick=”Inarticle articleshow link click#Tech#href” target=”_blank” href=”https://economictimes.indiatimes.com/tech/policybazaar”>Policybazaar, declined nearly 5% on Wednesday after the company’s proposal to infuse Rs 696 crore in its healthcare arm failed to cheer investors. The scrip of ref=”dofollow” data-ga-onclick=”Inarticle articleshow link click#Tech#href” target=”_blank” href=”https://economictimes.indiatimes.com/pb-fintech-ltd/stocks/companyid-2017710.cms”>PB Fintech tanked 4.70% to close at Rs 1,399.95 apiece on the ref=”dofollow” data-ga-onclick=”Inarticle articleshow link click#Tech#href” href=”https://economictimes.indiatimes.com/topic/national-stock-exchange” target=”_blank”>National Stock Exchange (NSE).
On the BSE, it fell 4.44% to settle at Rs 1,404.15 per share.
In volume terms, 46.18 lakh equity shares of rel=”dofollow” href=”https://economictimes.indiatimes.com/pb-fintech-ltd/stocks/companyid-2017710.cms” data-ga-onclick=”Inarticle articleshow link click#Tech#href” target=”_blank”>PB Fintech were traded on the NSE, and 1.23 lakh scrips exchanged hands on the BSE during the day.
The 30-share data-ga-onclick=”Inarticle articleshow link click#Tech#href” target=”_blank” href=”https://economictimes.indiatimes.com/indices/sensex_30_companies”>BSE Sensex fell 72.56 points to close at…
